维普期刊资源整合服务平台（V6.5）

62篇 您的检索式：作者名="Hoogwerf B"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Ramipril and the development of diabetes显示文摘	Yusuf S Gerstein H Hoogwerf B		0，，：	1
2	Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy显示文摘	Lonn E Yusuf S Hoogwerf B	2002	Diabetes Care2002，25，11：	1
3	Ramipril and the development of diabetes显示文摘	Gerstein H Hoogwerf B	2001	JAMA2001，286，15：	1
4	Renin-angiotensin system blockade and cardiovascular and renal protection显示文摘	Hoogwerf B J	2010	Am J Cardiol2010，105，1：	1
5	Effects of vitamin E on cardi- ovascular and microvascular outcomes in high-risk patients with diabetes:results of the HOPE study and MICRO-HOPE substudy 显示文摘	Lonn E Yusuf S Hoogwerf B	2002	Diabetes Care2002，25，11：	1
6	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon- like peptide I(GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
7	Effect of exeuatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study 显示文摘	Gill A Hoogwerf B J Burger J	2010	Car- diovasc diabetol2010，9，：	1
8	HOPE study investigators, ramipil and the development of diabetes显示文摘	Yusuf S Gerstein H Hoogwerf B	2001	JAMA2001，286，：	1
9	Ramipril and the development of diabetes 显示文摘	Yusuf S Gerstein H Hoogwerf B	2001	JAMA2001，286，：	1
10	The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes:a randomized trial显示文摘	Zinman B Hoogwerf BJ Duran Garcia S	2007	Ann Intern Med2007，146，7：	1
11	Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double- blind, placebo-controlled, randomized pilot study 显示文摘	Gill A Hoogwerf B J Burger J	2010	Cardiovasc Diabetol2010，9，：	1
12	The ef ect of adding exenatide to a thiazolidinedione in suboptimal y control ed type 2 diabetes:a randomized trial显示文摘	Zinman B Hoogwerf BJ Duran Chrcia S		0，，07：	1
13	Ramipril and the devel- opment of diabetes显示文摘	Yusuf S Gerstein H Hoogwerf B	2001	JAMA2001，286，15：	1
14	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the lifeline database 显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
15	Fluid rtention after initiation of thiazolidinedione herapy in diabetic patients with established chronic heart failure 显示文摘	Tang W Francis G Hoogwerf B	2003	J Am Coil Cardio12003，41，8：	1
16	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon- like peptide I(GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the Life Link database显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
17	The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type2 diabetes:a randomized trial显示文摘	Zinman B Hoogwerf B J Duran Gracia S	2007	Ann Intern Med2007，146，7：	1
18	The effect of adding Exenatide to a tbiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial 显示文摘	Z1NMAN B HOOGWERF B J DURAN G S	2007	Ann Intern Med2007，146，7：	1
19	The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial显示文摘	Zinman B Hoogwerf B J Duran Chrcia S	2007	Ann In-tern Meal2007，146，7：	1
20	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon- like peptide I(GLP-1) receptor agonist exenatide twice daily or other glucose lowering therapies : a retrospective analysis of the Life Link database显示文摘	Best J H Hoogwerf B J Herman W H	2011	Diabetes Care2011，34，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示